Endometrial cancer and hypermethylation: Regulation of DNA and MicroRNA by epigenetics

Biochemistry Research International

Volumn , Issue , 2012, Pages

  Banno, Kouji ^a   Kisu, Iori ^a   Yanokura, Megumi ^a   Masuda, Kenta ^a   Kobayashi, Yusuke ^a   Ueki, Arisa ^a   Tsuji, Kosuke ^a   Yamagami, Wataru ^a   Nomura, Hiroyuki ^a   Susumu, Nobuyuki ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861033736     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2012/738274     Document Type: Review

References (38)

1. Esteller M., Epigenetics in cancer New England Journal of Medicine 2008 358 11 1148 1159
2. Wajed S. A., Laird P. W., DeMeester T. R., DNA methylation: an alternative pathway to cancer Annals of Surgery 2001 234 1 10 20 (Pubitemid 32619329)
3. Muraki Y., Banno K., Yanokura M., Kobayashi Y., Kawaguchi M., Nomura H., Hirasawa A., Susumu N., Aoki D., Epigenetic DNA hypermethylation: clinical applications in endometrial cancer Oncology Reports 2009 22 5 967 972
4. Velasco A., Pallares J., Santacana M., Gatius S., Fernandez M., Domingo M., Valls J., Yeramian A., Encinas M., Dolcet X., Matias-Guiu X., Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma Human Pathology 2011 42 2 185 193
5. Pallares J., Velasco A., Eritja N., Santacana M., Dolcet X., Cuatrecasas M., Palomar-Asenjo V., Catasus L., Prat J., Matias-Guiu X., Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma Modern Pathology 2008 21 6 691 699 (Pubitemid 351744834)
6. Kang H. S., Baba T., Mandai M., Matsumura N., Hamanishi J., Kharma B., Kondoh E., Yoshioka Y., Oishi S., Fujii N., Murphy S. K., Konishi I., GPR54 is a target for suppression of metastasis in endometrial cancer Molecular Cancer Therapeutics 2011 10 4 580 590
7. Yi T. Z., Guo J., Zhou L., Chen X., Mi R. R., Qu Q. X., Zheng J. H., Zhai L., Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma Cancer Investigation 2011 29 1 86 92
8. Dewdney S. B., Rimel B. J., Thaker P. H., Thompson D. M., Schmidt A., Huettner P., Mutch D. G., Gao F., Goodfellow P. J., Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers Clinical Cancer Research 2011 17 8 2120 2129
9. Ignatov A., Bischoff J., Ignatov T., Schwarzenau C., Krebs T., Kuester D., Costa S. D., Roessner A., Semczuk A., Schneider-Stock R., APC promoter hypermethylation is an early event in endometrial tumorigenesis Cancer Science 2010 101 2 321 327
10. Satoh A., Toyota M., Itoh F., Sasaki Y., Suzuki H., Ogi K., Kikuchi T., Mita H., Yamashita T., Kojima T., Kusano M., Fujita M., Hosokawa M., Endo T., Tokino T., Imai K., Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer Cancer Research 2003 63 24 8606 8613 (Pubitemid 38064034)
11. Wang X., Yang Y., Xu C., Xiao L., Shen H., Zhang X., Li T., Li X., CHFR suppression by hypermethylation sensitizes endometrial cancer cells to paclitaxel International Journal of Gynecological Cancer 2011 21 6 996 1003
12. Lo T. L., Yusoff P., Fong C. W., Guo K., McCaw B. J., Phillips W. A., Yang H., Wong E. S. M., Leong H. F., Zeng Q., Putti T. C., Guy G. R., The Ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer Cancer Research 2004 64 17 6127 6136 (Pubitemid 39129413)
13. Sutterlty H., Mayer C. E., Setinek U., Attems J., Ovtcharov S., Mikula M., Mikulits W., Micksche M., Berger W., Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms Molecular Cancer Research 2007 5 5 509 520 (Pubitemid 46903958)
14. Fong C. W., Chua M. S., McKie A. B., Ling S. H. M., Mason V., Li R., Yusoff P., Lo T. L., Leung H. Y., So S. K. S., Guy G. R., Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma Cancer Research 2006 66 4 2048 2058
15. Holliday R., The inheritance of epigenetic defects Science 1987 238 4824 163 170 (Pubitemid 17139717)
16. Schofield P. N., Joyce J. A., Lam W. K., Grandjean V., Ferguson-Smith A., Reik W., Maher E. R., Genomic imprinting and cancer; new paradigms in the genetics of neoplasia Toxicology Letters 2001 120 13 151 160 (Pubitemid 32375081)
17. Peltomki P., Lynch syndrome genes Familial Cancer 2005 4 3 227 232
18. Kondo E., Furukawa T., Yoshinaga K., Kijima H., Semba S., Yatsuoka T., Yokoyama T., Fukushige S., Horii A., Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability. International journal of oncology 2000 17 3 535 541
19. Suter C. M., Martin D. I. K., Ward R. L., Germline epimutation of MLH1 in individuals with multiple cancers Nature Genetics 2004 36 5 497 501 (Pubitemid 38620035)
20. Hitchins M. P., Wong J. J. L., Suthers G., Suter C. M., Martin D. I. K., Hawkins N. J., Ward R. L., Inheritance of a cancer-associated MLH1 germ-line epimutation New England Journal of Medicine 2007 356 7 697 705
21. Goel A., Nguyen T. P., Leung H. C. E., Nagasaka T., Rhees J., Hotchkiss E., Arnold M., Banerji P., Koi M., Kwok C. T., Packham D., Lipton L., Boland C. R., Ward R. L., Hitchins M. P., De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one International Journal of Cancer 2011 128 4 869 878
22. Chan T. L., Yuen S. T., Kong C. K., Chan Y. W., Chan A. S. Y., Ng W. F., Tsui W. Y., Lo M. W. S., Tam W. Y., Li V. S. W., Leung S. Y., Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer Nature Genetics 2006 38 10 1178 1183 (Pubitemid 44470364)
23. van der Gun B. T. F., Melchers L. J., Ruiters M. H., de Leij L. F. M. H., McLaughlin P. M. J., Rots M. G., EpCAM in carcinogenesis: the good, the bad or the ugly Carcinogenesis 2010 31 11 1913 1921
24. Ligtenberg M. J. L., Kuiper R. P., Chan T. L., Goossens M., Hebeda K. M., Voorendt M., Lee T. Y. H., Bodmer D., Hoenselaar E., Hendriks-Cornelissen S. J. B., Tsui W. Y., Kong C. K., Brunner H. G., Van Kessel A. G., Yuen S. T., Van Krieken J. H. J. M., Leung S. Y., Hoogerbrugge N., Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 Nature Genetics 2009 41 1 112 117
25. Kozaki K. I., Imoto I., Mogi S., Omura K., Inazawa J., Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer Cancer Research 2008 68 7 2094 2105 (Pubitemid 351521781)
26. Furuta M., Kozaki K. I., Tanaka S., Arii S., Imoto I., Inazawa J., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma Carcinogenesis 2009 31 5 766 776
27. Pierson J., Hostager B., Fan R., Vibhakar R., Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma Journal of Neuro-Oncology 2008 90 1 1 7
28. Saito Y., Friedman J. M., Chihara Y., Egger G., Chuang J. C., Liang G., Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells Biochemical and Biophysical Research Communications 2009 379 3 726 731
29. Nakano H., Miyazawa T., Kinoshita K., Yamada Y., Yoshida T., Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-XLin colorectal cancer cells International Journal of Cancer 2010 127 5 1072 1080
30. Huang Y. W., Liu J. C., Deatherage D. E., Luo J., Mutch D. G., Goodfellow P. J., Miller D. S., Huang T. H. M., Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer Cancer Research 2009 69 23 9038 9046
31. Tsuruta T., Kozaki K. I., Uesugi A., Furuta M., Hirasawa A., Imoto I., Susumu N., Aoki D., Inazawa J., miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer Cancer Research 2011 71 20 6450 6462
32. Stumpel D. J. P. M., Schotte D., Lange-Turenhout E. A. M., Schneider P., Seslija L., De Menezes R. X., Marquez V. E., Pieters R., Den Boer M. L., Stam R. W., Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale Leukemia 2011 25 3 429 439
33. Chen Y., Song Y., Wang Z., Yue Z., Xu H., Xing C., Liu Z., Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance Journal of Gastrointestinal Surgery 2010 14 7 1170 1179
34. Braconi C., Huang N., Patel T., Microrna-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes Hepatology 2010 51 3 881 890
35. Chen H. Z., Tsai S. Y., Leone G., Emerging roles of E2Fs in cancer: an exit from cell cycle control Nature Reviews Cancer 2009 9 11 785 797
36. Trusolino L., Bertotti A., Comoglio P. M., MET signalling: principles and functions in development, organ regeneration and cancer Nature Reviews Molecular Cell Biology 2010 11 12 834 848
37. Roulin D., Cerantola Y., Dormond-Meuwly A., Demartines N., Dormond O., Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo Molecular Cancer 2010 9, article no. 57
38. Guertin D. A., Stevens D. M., Saitoh M., Kinkel S., Crosby K., Sheen J. H., Mullholland D. J., Magnuson M. A., Wu H., Sabatini D. M., mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice Cancer Cell 2009 15 2 148 159